Next Frontier Biosciences, Inc. — Form D
Next Frontier Biosciences, Inc. of WESTMINSTER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2020-01-24. The offering totals $1.2M, of which $826K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2020-01-24
- Form: D
- Accession: 0001628804-20-000004
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $1.2M
- Amount sold: $826K
- Remaining: $374K
- Investors: 27
- Date of first sale: 2020-01-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-358921
Issuer
- Name: Next Frontier Biosciences, Inc.
- CIK: 0001628804
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 6510 W. 91st Avenue, Suite 106, WESTMINSTER, CO, 80031
- Phone: 303-550-3133
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Marc Graboyes | Director | Deerfield Beach, FL |
| Paul Johnson | Director | Scottsdale, AZ |
| James Kreitman | Director | Westminster, CO |
| Charles Sander | Director | Westminster, CO |
| Marc Graboyes | Executive Officer | Deerfield Beach, FL |
| Marc Graboyes | Promoter | Deerfield Beach, FL |
| Peter Johnson | Promoter | Los Gatos, CA |
| Paul Johnson | Executive Officer | Scottsdale, AZ |
Other filings by this issuer (8)
More